Jill Biden on Wednesday on her way to the Marine One helicopter that took her to the hospital
US First Lady Jill Biden has undergone ambulatory skin surgery.
Cancer tissue was removed.
The surgery went well, White House medic Kevin O'Connor said on Wednesday.
All of the cancerous tissue was "successfully" removed from the affected areas.
The 71-year-old, as expected, has some swelling and bruising on her face but is feeling fine, O'Connor said.
Biden wanted to leave the hospital on the same day.
The procedure, known as Mohs surgery, was performed at the Walter Reed National Military Medical Center in Bethesda, Maryland, near the US capital Washington.
According to the White House, Jill Biden was accompanied by the President.
During a routine skin cancer screening, the First Lady was found to have "a small lesion above her right eye," according to her spokeswoman.
The intervention has now confirmed that it was a so-called basal cell carcinoma, said O'Connor.
Another "area of concern" was also discovered on the left side of the 71-year-old's chest.
The tissue was also removed – a basal cell carcinoma was confirmed.
Here, too, the entire cancerous tissue was successfully removed.
There were no remnants of skin cancer cells at the edges of the lesion.
A basal cell carcinoma, or basal cell carcinoma, is a tumor that, unlike a melanoma, does not usually metastasize.
Basalioma is also known as light or white skin cancer.
"We will be monitoring the area closely as it heals, but anticipate no further intervention will be necessary."
The procedure also removed a lesion on Jill Biden's left eyelid, which is now being examined in the laboratory, it was said.
The result of the examination of these samples was not yet available.